GenSight Biologics S.A.
GSGTF
$0.19
-$0.05-20.79%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.95M | -3.67M | -4.35M | -4.48M | -3.15M |
| Total Depreciation and Amortization | 97.60K | 90.50K | 259.00K | 267.10K | 308.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 80.60K | 74.70K | 227.10K | 234.20K | -696.40K |
| Change in Net Operating Assets | 2.38M | 2.21M | 878.90K | 906.40K | -417.60K |
| Cash from Operations | -1.40M | -1.29M | -2.98M | -3.07M | -3.95M |
| Capital Expenditure | -- | -- | 0.00 | 0.00 | -500.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -30.10K | -27.90K | 2.70K | 2.70K | 7.00K |
| Cash from Investing | -30.10K | -27.90K | 2.70K | 2.70K | 6.50K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -177.00K | -177.00K | -1.24M | -1.24M | -203.50K |
| Issuance of Common Stock | 362.00K | 362.00K | 1.60M | 1.60M | 5.40M |
| Repurchase of Common Stock | -- | -- | -2.50K | -2.50K | -11.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -29.50K | -29.50K | 348.50K | 348.50K | 885.00K |
| Cash from Financing | 176.50K | 163.60K | 749.90K | 773.40K | 6.53M |
| Foreign Exchange rate Adjustments | 4.50K | 4.20K | -158.30K | -163.30K | 2.20K |
| Miscellaneous Cash Flow Adjustments | -600.00 | -500.00 | -- | -- | -- |
| Net Change in Cash | -1.25M | -1.15M | -2.39M | -2.46M | 2.59M |